Bank Of Montreal Castle Biosciences Inc Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$39.06 - $67.58 $1.75 Million - $3.03 Million	-44,818 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $102,221 - $131,920	-1,700 Reduced 3.65%	44,818 $3.3 Million
Q2 2021 Aug 12, 2021	BUY	$50.07 - $76.78 $2.33 Million - $3.57 Million	46,518 New	46,518 $3.51 Million

202

26M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $739M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.